Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Silvia-E. Glont"'
Publikováno v:
Cell Reports, Vol 26, Iss 10, Pp 2558-2565.e3 (2019)
Summary: Considerable work has linked hormone receptors, such as estrogen receptor-alpha (ER), with the pioneer factor FOXA1. Altered FOXA1 levels contribute to endocrine-resistant breast cancer, where it maintains ER-chromatin interactions, even in
Externí odkaz:
https://doaj.org/article/0101840afb224a3eaaa1683078f86a60
Autor:
Silvia-E Glont, Evangelia K Papachristou, Ashley Sawle, Kelly A Holmes, Jason S Carroll, Rasmus Siersbaek
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215340 (2019)
Estrogen Receptor alpha (ERα) plays a major role in most breast cancers, and it is the target of endocrine therapies used in the clinic as standard of care for women with breast cancer expressing this receptor. The two methods ChIP-seq (chromatin im
Externí odkaz:
https://doaj.org/article/240c6a016e47436084a7142bf756f9cb
Autor:
Rasmus Siersbæk, Kelly A. Holmes, Jason S. Carroll, Silvia-E. Glont, Ashley Sawle, Evangelia K. Papachristou
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215340 (2019)
Estrogen Receptor alpha (ERα) plays a major role in most breast cancers, and it is the target of endocrine therapies used in the clinic as standard of care for women with breast cancer expressing this receptor. The two methods ChIP-seq (chromatin im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7555ffa9f8ea0ab1fbd0c1465c03f2cb
https://doaj.org/article/240c6a016e47436084a7142bf756f9cb
https://doaj.org/article/240c6a016e47436084a7142bf756f9cb